Heterotopic ossification happens when bone grows outside of its normal location and into the surrounding soft tissues of your body. When this happens, the pieces of bone that develop are called ...
The doctors and nurses at the emergency room in Jacksonville, Florida, were “perplexed,” as Dia Thomas remembers it. They believed her when she said she was in pain—imaging had revealed fractures in ...
The American Society of Clinical Oncology first published evidence-based practice guidelines for the use of bisphosphonates in breast cancer in 2000 and updated them in 2003. To reflect the proven ...
Multiple myeloma is an uncommon cancer affecting plasma cells in the bone marrow. Tumors in the bones and other organs can cause the cells to grow out of control. A complication of this cancer is ...
Share on Pinterest A study of bone scans is helping scientists determine the prevalence of cardiac amyloidosis. Ben Hasty/MediaNews Group/Reading Eagle via Getty Images Cardiac amyloidosis (CA) causes ...
Starting bisphosphonates in women who demonstrate bone destruction through imaging but who have normal plain radiographs is considered reasonable treatment. Starting bisphosphonates in women with only ...
Bone Loss Lessened by Blocking Abnormal Stem Cell Signal September 28, 2023 A new study in mice led by researchers from NYU Grossman School of Medicine found that blocking the signaling pathway, ...
Drug trial shows reduced abnormal bone formation in those with fibrodysplasia ossificans progressiva
A multisite, international phase 2 trial evaluating the investigational drug garetosmab has shown that it reduced soft-tissue flare-ups significantly and prevented new areas of abnormal bone formation ...
March 2, 2011 — An updated guideline on the use of bone-modifying agents in patients with metastatic breast cancer have been issued by the American Society of Clinical Oncology (ASCO). The guideline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback